Evidence map›Paper›PMID 39790751›Full record

ArticleJournal of family medicine and primary care2024

Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients.

K Naja, Durga Shankar Meena, Deepak Kumar, Naveen Dutt, Gopal K Bohra, Ravisekhar Gadepalli, Mithu Banerjee, Mahendra K Garg, Sanjeev Misra

Abstract read
In one paragraph

Article in Journal of family medicine and primary care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

K NajaDepartment of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Durga Shankar MeenaDepartment of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Deepak KumarDepartment of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Naveen DuttDepartment of Pulmonary Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Gopal K BohraDepartment of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Ravisekhar GadepalliDepartment of Microbiology, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Mithu BanerjeeDepartment of Biochemistry, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Mahendra K GargDepartment of Internal Medicine, All India Institute of Medical Sciences, Jodhpur, Rajasthan, India.
Sanjeev MisraVice Chancellor, Atal Bihari Vajpayee Medical University, Lucknow, Uttar Pradesh, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: It is documented that COVID-19 survivors have prolonged morbidity and functional impairment for many years. Data regarding post-COVID-19 lung functions is lacking from the Indian population. We aim to evaluate the lung functions in such patients after 3-6 months of hospital discharge. Methods: In this prospective observational study, patients were assessed 3 to 6 months post-discharge and underwent standardized pulmonary function tests (PFTs) and CT Thorax if required. The following parameters were measured and correlated with the disease severity: Forced Vital Capacity (FVC), Forced Expiratory Volume in the First Second (FEV1), Forced Expiratory Flows at 25 and 75% of FVC (FEF25%-75%), Peak Expiratory Flow (PEF) and FEV1/FVC. Results: A total of 52 post-COVID-19 patients were enrolled in the study, with a median age of 43 years (78.8% males). 44.2% of patients had mild disease, 26.9% had moderate disease and 23.1% had severe disease at hospital admission. A restrictive pattern was seen in 20.8% of patients. The mean value of FEV1 and FVC decreased as the disease severity increased. FEV1: mild-3.21 ± 0.71, moderate-2.62 ± 0.61 and severe- 2.51 ± 0.72, Conclusions: Patients with COVID-19 pneumonia, which required oxygen, especially severe disease at the time of hospitalization, had a higher rate of abnormal spirometry than patients with mild symptoms. Follow-up CT scans obtained within six months of disease onset showed abnormalities in more than half of patients, particularly elderly patients.

Indexed as

COVID-19lung function testPFTpneumoniaspirometry

Identifiers

PMID39790751
PMCPMC11709076

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.